Manufacturing / Electronic Components & Accessories
NVIDIA CORP
NVDA
$210.29
-$0.40 (-0.19%)
5400 B
Market Cap (Mega Cap)
17%
IV Rank
35.8%
Implied Volatility
Aug 25
Next Earnings
Insider Trades
0 buys
671 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 08, 2026 | GAWEL SCOTT | Grant | 13,866 | $0 | |
| Jun 08, 2026 | GAWEL SCOTT | Grant | 45,643 | $0 | |
| Jun 08, 2026 | GAWEL SCOTT | Other | 13,866 | $0 | |
| Jun 08, 2026 | GAWEL SCOTT | Other | 45,643 | $0 | |
| Jun 04, 2026 | STEVENS MARK A | Gift | 307,500 | $0 | |
| Jun 04, 2026 | STEVENS MARK A | Sell | 400,000 | $88,148,400 | |
| Jun 04, 2026 | STEVENS MARK A | Sell | 100,000 | $21,765,500 | |
| Jun 04, 2026 | STEVENS MARK A | Other | 307,500 | $0 | |
| Jun 04, 2026 | STEVENS MARK A | Other | 400,000 | $88,148,400 | |
| Jun 04, 2026 | STEVENS MARK A | Other | 100,000 | $21,765,500 |
Politician Trades in NVDA
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| May 08, 2026 | Sheldon Whitehouse | D | Sale | $100K-$250K |
| May 08, 2026 | Sheldon Whitehouse | D | Sale | $100K-$250K |
| May 08, 2026 | Sheldon Whitehouse | D | Sale | $100K-$250K |
| May 08, 2026 | Sheldon Whitehouse | D | Sale | $100K-$250K |
| May 08, 2026 | Sheldon Whitehouse | D | Sale | $100K-$250K |
| May 08, 2026 | Sheldon Whitehouse | D | Sale | $100K-$250K |
| Apr 15, 2026 | John J. McGuire | R | Purchase | $1K-$15K |
| Apr 14, 2026 | Gil Cisneros | D | Sale | $1K-$15K |
| Apr 13, 2026 | Ro Khanna | D | Purchase | $1K-$15K |
| Apr 08, 2026 | Elizabeth Pannill Fletcher | D | Sale | $1K-$15K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| May 20, 2026 | Q1 2027 | $1.79 | |||
| Mar 31, 2026 | Q4 2026 | $1.56 | $1.62 | +3.6% | Beat |
| Dec 31, 2025 | Q3 2026 | $1.27 | $1.30 | +2.0% | Beat |
| Sep 30, 2025 | Q2 2026 | $1.03 | $1.05 | +2.1% | Beat |
| Jun 30, 2025 | Q1 2026 | $0.95 | $0.96 | +0.8% | Beat |
Track NVDA with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for NVDA and your entire portfolio.